Talphera Inc to Host Investor and Analyst Event Transcript
(audio in progress) I'd now like to turn the call over to Vince Angatti, Chief Executive Officer at Telfera. Please go ahead.
Thank you, Tara, and good morning everyone, and thank you for joining our event today.
I'm excited to be joined by Dr. Shaquille Aslam, Telfair's Chief Medical Officer, and two key experts in continuous renal replacement therapy, who are also principal investigators in our Nephro-CRRT registrational study.
Through their experience and expertise, we hope to provide you with a better understanding of CRRT.
The anticoagulants currently being used during CRRT and how these experts see nafamiat potentially filling an unmet need for anticoagulation of the CRRT circuit. Our agenda will specifically include first, A very brief business update so we can move quickly to our key expert discussion followed by Q&A and closing remarks.
Before we begin, I remind listeners that during this call we'll likely make forward-look statements within the meaning
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
